Aortic valve replacement is a procedure that replaces the leaking or diseased aortic heart valve with an artificial one. The advantage of this procedure is that it can be done without open-heart surgery, which means less risk and complications for people who are not healthy enough to undergo open-heart surgery. However, there are risks associated with this procedure as well such as stroke and infection. The section below will discuss the benefits and risks associated with aortic valve replacement without open-heart surgery.
What is Aortic Stenosis?
Aortic stenosis is a heart condition that causes the valve between the left ventricle and the aorta to narrow. It can be caused by rheumatic fever, congenital diseases, or atherosclerosis. Symptoms include chest pain when you exert yourself, dizziness and fainting spells, shortness of breath with light activity, fatigue, and irregular heartbeat.
While there are treatments available for patients in Stage A (minimal symptoms) through C (severe symptoms), some people may not experience any symptoms until it’s too late to treat effectively without surgery – which isn’t an option if they’ve already been diagnosed with cancer.
In this situation, many physicians will recommend doing nothing unless necessary because even though open-heart surgery would save the patient, it has many risks.
Aortic valve replacement without open-heart surgery is an effective alternative because the procedure can help reduce pain and prevent life-threatening complications. It’s also minimally invasive, making the recovery time much shorter than that for traditional open-heart methods. If you’re looking for the best treatment hospital, then you must consider none other than Maxhospitalindia
Aortic stenosis is traditionally treated with open cardiac surgery
The traditional treatment of open cardiac surgery replaces or repairs the faulty valve while keeping the heart beating. This type of treatment has become more common in recent years because it is less invasive than open cardiac surgery, has shorter hospital stays, and has faster recovery times. But for some patients, surgery is too risky to be considered an option.
Then doctors must look beyond traditional treatments and consider alternatives like aortic valve replacement without open-heart surgery (AVRWOHS). However, AVRWOHS does have its own set of risks that are worth considering before deciding if this is right for you.
Aortic stenosis is treated using TAVR, a catheter-based procedure
The procedure is performed through a small incision in the groin, allowing patients to get up and walk within an hour after surgery. The patient can typically go home from the hospital on the next day of the surgery. This reduces recovery time significantly compared with open heart surgery (the traditional way) which involves months of recovery depending on each individual’s condition.
The average length of hospital stay for TAVR treatment is fewer than three days compared to an average stay of five days or more with traditional aortic valve replacement procedures. There’s not much time spent in healthcare; this minimizes exposure to infectious diseases such as pneumonia and blood clots while promoting faster recovery times. The lack of open-heart surgery also reduces the risk of heart attack and stroke in patients, which has become increasingly popular.
Benefits and risks of TAVR
The first TAVR clinical trials, which commenced in 2007, looked at TAVR in people who were too sick for SAVR. These studies demonstrated that improving the quality and duration of life of individuals with severe AS was beneficial. Since then, tests comparing TAVR versus SAVR have been conducted in individuals deemed high risk and intermediary risk for conventional SAVR. TAVR was proven to be no poorer or perhaps even superior to SAVR in every one of those trials. Due to the apparent fast recovery time with TAVR, it quickly became the pattern of therapy for patients with AS who were at moderate or high operations to improve.
The current TAVR news covers clinical studies with the healthiest patients or those regarded as low-risk surgery prospects. In March 2019, the PARTNER 3 Test and the CoreValve Low-Risk Test were both reported at the American College of Cardiology Meetings. Both studies found that TAVR had substantial advantages to SAVR, such as lower mortality risks, stroke, and recurrent hospitalizations. The FDA is anticipated to approve TAVR in limited patients within the coming years. TAVR will, after that, become the standard of treatment for all adults with AS.
Although TAVR provides several advantages, it is not without danger, as with any significant cardiac operation. Cardiac arrest, stroke, bleeding, and the necessity for immediate surgery are all possible hazards, but minor. Then there is the possibility of harm to the heart’s power system, which might need the implantation of a lifelong pacemaker.
Is TAVR correct for you?
If you are 75 or older, have a high risk of stroke and small vessel disease in the brain, this may be right for you. This is also true if your heart can’t keep blood flowing throughout your body because it is too weak to work properly. You might benefit from less invasive treatment without open-heart surgery by having TAVR.
Tavr has many benefits associated with it, but there are also some risks you should be aware of before choosing this treatment option.
